MDA taps Bridgebio funding to improve LGMD care coordination
WHY IT MATTERS
LGMD patients often struggle to find doctors who understand their condition and coordinate care across specialties; this funding directly supports programs at two major medical centers to make that coordination easier and more accessible.
A company called Bridgebio is giving $100,000 to the Muscular Dystrophy Association to help improve how doctors care for patients with limb-girdle muscular dystrophy (LGMD), a rare muscle disease. Two hospitals—Stanford Health Care and the University of Minnesota—will use this money to make it easier for LGMD patients to get coordinated care from multiple specialists in one place.
Bridgebio is providing $100,000 to the Muscular Dystrophy Association (MDA) to advance projects aimed at improving multidisciplinary care for people with limb-girdle muscular dystrophy (LGMD). The awards will go to initiatives at Stanford Health Care and the University of Minnesota that aim to make LGMD care more coordinated, accessible, and flexible for patients across the […] The post MDA taps Bridgebio funding to improve LGMD care coordination appeared first on Muscular Dystrophy News .